Skip to main content
. 2017 Sep 6;72(11):3131–3140. doi: 10.1093/jac/dkx283

Figure 4.

Figure 4.

Hazard ratio versus the duration of miltefosine concentration >EC90 (Time > EC90). Lines indicate the estimated hazard ratios for the combination therapy (left panel) and miltefosine monotherapy (right panel). Grey areas represent the respective computed 90% CI. Circles represent the observed individuals: open circles represent cured patients, while filled circles represent patients who relapsed and received rescue treatment.